P/E ratio for Merit Medical (MMSI)
P/E ratio as of April 2024 (TTM): 42.2
According to Merit Medical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.1724. At the end of 2022 the company had a P/E ratio of 53.9.
P/E ratio history for Merit Medical from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 53.9 | -25.58% |
| 2021 | 72.4 | -122.19% |
| 2020 | -327 | -194.13% |
| 2019 | 347 | 397.24% |
| 2018 | 69.8 | -4.72% |
| 2017 | 73.2 | 24.34% |
| 2016 | 58.9 | 71.06% |
| 2015 | 34.4 | 7.27% |
| 2014 | 32.1 | -20.48% |
| 2013 | 40.4 | 36.47% |
| 2012 | 29.6 | 34.83% |
| 2011 | 21.9 | -39.38% |
| 2010 | 36.2 | 71.14% |
| 2009 | 21.1 | -10.38% |
| 2008 | 23.6 | -3.26% |
| 2007 | 24.4 | -30.72% |
| 2006 | 35.2 | 71.07% |
| 2005 | 20.6 | -8.43% |
| 2004 | 22.5 | -33.05% |
| 2003 | 33.6 | 36.89% |
| 2002 | 24.5 | -13.11% |
| 2001 | 28.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.4 | -75.28% | 🇺🇸 USA |
 Medtronic MDT | 29.1 | -30.91% | 🇮🇪 Ireland |
 Boston Scientific BSX | 89.3 | 111.85% | 🇺🇸 USA |
 Edwards Lifesciences EW | 37.5 | -11.20% | 🇺🇸 USA |
 Teleflex TFX | 24.0 | -43.01% | 🇺🇸 USA |
 ICU Medical
ICUI | -46.8 | -210.97% | 🇺🇸 USA |
 AngioDynamics ANGO | 36.1 | -14.34% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.